ArticleJournal of clinical laboratory analysis2026
The Neutrophil-To-Lymphocyte Ratio as an Associated Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus.
Article in Journal of clinical laboratory analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
BACKGROUND AND
objectiveChronic low-grade inflammation drives the development and progression of type 2 diabetes mellitus (T2DM) and microvascular complications, including diabetic kidney disease. The neutrophil-to-lymphocyte ratio (NLR) is a routine hematological index reflecting systemic inflammatory activity. This study evaluated NLR's association with T2DM, glycemic control, and renal function in a Hodeidah City cohort, assessing renal function via the CKD-EPI creatinine equation.
methodsContinuous variables were expressed as medians (interquartile ranges) and analyzed using nonparametric tests. Associations were evaluated via Spearman correlation and exploratory linear regression.
resultsPrimary comparisons revealed that T2DM patients possessed a significantly higher NLR than healthy controls, confirming a systemic inflammatory phenotype. Within the T2DM group, NLR did not differ significantly across HbA1c (p = 0.066) or eGFR categories (p = 0.328). However, NLR positively correlated with serum creatinine (Spearman ρ = 0.352, p = 0.022) and demonstrated an inverse, nonsignificant association with eGFR (ρ = -0.275, p = 0.078).
conclusionsNLR may serve as a practical adjunctive inflammatory biomarker in T2DM. Nevertheless, accurate clinical interpretation requires careful adjustment for renal function, comorbidities, and medication exposure. The absence of comprehensive data regarding the albumin-to-creatinine ratio (ACR), diabetes duration, and specific medication history limited multivariable confounder adjustment and complete nephropathy staging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.